Form 4: Sabra Health Care REIT CEO Richard Matros Acquires Shares Through Dividend Equivalent Payments
SEC Form 4 Filing
Richard Matros, CEO of Sabra Health Care REIT, acquired 11,255 shares through dividend equivalent payments and holds 1,472,841 shares indirectly through a revocable trust.
Summary
- Richard Matros, the Chair, CEO, and President of Sabra Health Care REIT, acquired 11,255 shares of common stock on November 29, 2024.
- These shares were acquired through dividend equivalent payments on previously granted stock units.
- The acquisition price was $0, as these were not purchased directly but rather awarded as dividend equivalents.
- Following this transaction, Mr. Matros directly owns 714,023 shares and indirectly owns 1,472,841 shares through the R&A Matros Revocable Trust.
- The stock units will vest and become payable on the same terms as the original stock units to which they relate.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively by investors. The increase in share ownership by the CEO is a positive sign.
Positives
- The acquisition of shares through dividend equivalents demonstrates alignment of the CEO's interests with those of shareholders.
- The increase in share ownership by the CEO could be seen as a positive sign of confidence in the company's future performance.
Industry Context
This is a routine filing related to executive compensation and is common in the REIT industry where stock-based compensation is a significant part of executive pay.
Comparison to Industry Standards
- Executive stock ownership is a common practice in publicly traded REITs, aligning management's interests with shareholders.
- Dividend equivalent payments are a standard method of compensating executives with stock units, ensuring they benefit from company performance.
- The level of ownership is not unusual for a CEO of a company of this size, and is comparable to other REIT executives.
Stakeholder Impact
- The increase in share ownership by the CEO could be viewed positively by shareholders, indicating confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of the stock acquisition through dividend equivalent payments. |
| 12/03/2024 | Date the Form 4 was signed by Michael Costa, as Attorney-in-Fact. |
Keywords
Sabra Health Care REIT, Richard Matros, stock acquisition, dividend equivalent, insider trading, Form 4, executive compensation, share ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.